Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biogen
5
×
biotech
boston blog main
5
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
venture capital
5
×
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
ipo
national
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
cancer
crispr
fda
startups
vc
biomarin pharmaceutical
car-t
celgene
clinical trials
What
bio
roundup
ipo
medicines
new
ceo
covid
years
acquisitions
activity
aims
allogene
announced
approvals
backed
becker
billions
biogen
cancer
cause
clamped
collabs
crispr
daniel
deal
delays
developing
diversity
dollars
drugs
eaton
economic
epilepsy
fast
fda
gene
genes
genetic
gilead
gilead’s
Language
unset
Current search:
biogen
×
" venture capital "
×
" boston blog main "
×
@xconomy.com
4 years ago
Backed by $100M, Praxis Aims to Turn Epilepsy Research Into New Neuro Drugs
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Michael Becker, Suzanne Eaton, Gene Therapy Moves & More
@xconomy.com
5 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
